En savoir plus
MD Anderson and Federation Bio Announce Collaboration to Develop Novel Microbiome Treatment for Patients with Immunotherapy-Resistant Cancers
Collaboration joins MD Anderson's expertise and...
Billennium integrates IDnow solution into its Inperly app
Billennium, a global IT solutions provider for...
Ingenico and Izicap announce a strategic partnership
Ingenico and Izicap announce a strategic partnership to...
Enterome completes patient enrollment of Phase 2 ROSALIE study evaluating its lead immunotherapy, EO2401, in recurrent glioblastoma
Enterome, a clinical stage company developing...
Enterome presents two posters on Phase 2 data of its lead immunotherapy, EO2401, in recurrent glioblastoma (ROSALIE study) at ESMO IO 2022
Enterome, a clinical stage biopharmaceutical company...
HUBDAY Future of Retail & E-Commerce
Come & meet us !
France Digital Tour – Bordeaux
FRANKFURT DIGITAL FINANCE
Paris Fintech Forum